FC
IONS icon

FORA Capital’s Ionis Pharmaceuticals IONS Stock Holding History

FORA Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Buy
+19,693
New +$1.55M 0.11% 191
2025
Q2 		– Sell
-11,570
Closed -$349K – 599
2025
Q1 		$349K Buy
+11,570
New +$379K 0.04% 383
2024
Q4 		– Sell
-5,081
Closed -$204K – 486
2024
Q3 		$204K Buy
+5,081
New +$236K 0.02% 403
2022
Q2 		– Sell
-6,095
Closed -$218K – 552
2022
Q1 		$218K Buy
+6,095
New +$199K 0.04% 468
2020
Q3 		– Sell
-4,838
Closed -$285K – 808
2020
Q2 		$285K Buy
+4,838
New +$269K 0.1% 269

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FORA Capital's IONS Position: Q1 2026 in Review

FORA Capital opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 19,693 shares worth $1.48M. The stake represents 0.11% of the portfolio and ranks #191 among its holdings. This is a return to the name: FORA Capital previously reported a position in IONS as recently as Q1 2025.

FORA Capital first reported a position in IONS in Q2 2020 and has held it in 5 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • FORA Capital held 19,693 shares of Ionis Pharmaceuticals worth $1.48M as of Q1 2026.
  • Ionis Pharmaceuticals was a new FORA Capital position in Q1 2026.
  • Ionis Pharmaceuticals made up 0.11% of FORA Capital's portfolio in Q1 2026, its #191 holding.
  • FORA Capital first reported a position in Ionis Pharmaceuticals in Q2 2020 and has held it in 5 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.